MindMed (MND.Q) announces intravenous DMT Phase 1 study Post date July 28, 2021 Posted by Piers Eaton Posted in Biotech, Eaton, Health Science, Intravenous, MindMEd, mmed.ne, Phase 1 Study, Psychedelics, Scribes, Switzerland, UHB Comments 0